1. Home
  2. Labeler Index
  3. Amylyx Pharmaceuticals Inc
  4. 73063-035
  5. NDC Package Code: 73063-035-04 Relyvrio

NDC Package 73063-035-04 Relyvrio

Sodium Phenylbutyrate/taurursodiol Powder, For Suspension Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
73063-035-04
Package Description:
7 POWDER, FOR SUSPENSION in 1 CARTON
Product Code:
73063-035
Proprietary Name:
Relyvrio
Non-Proprietary Name:
Sodium Phenylbutyrate/taurursodiol
Substance Name:
Sodium Phenylbutyrate; Taurursodiol Dihydrate
Usage Information:
RELYVRIO is indicated for the treatment of amyotrophic lateral sclerosis (ALS) in adults.
11-Digit NDC Billing Format:
73063003504
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
7 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 2613968 - sodium phenylbutyrate 3 GM / taurursodiol 1 GM Powder for Oral Suspension
  • RxCUI: 2613968 - sodium phenylbutyrate 3000 MG / taurursodiol 1000 MG Powder for Oral Suspension
  • RxCUI: 2613974 - relyvrio 3 GM / 1 GM Powder for Oral Suspension
  • RxCUI: 2613974 - sodium phenylbutyrate 3000 MG / taurursodiol 1000 MG Powder for Oral Suspension [Relyvrio]
  • RxCUI: 2613974 - Relyvrio (sodium phenylbutyrate 3 GM / taurursodiol 1 GM) Powder for Oral Suspension
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Amylyx Pharmaceuticals Inc
    Dosage Form:
    Powder, For Suspension - An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a suspension (a liquid preparation containing the solid particles dispersed in the liquid vehicle).
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • SODIUM PHENYLBUTYRATE 3 g/1
  • TAURURSODIOL DIHYDRATE 1 g/1
    • Pharmacologic Class(es):
  • Ammonium Ion Binding Activity - [MoA] (Mechanism of Action)
  • Nitrogen Binding Agent - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    NDA216660
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    09-29-2022
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    73063-035-0356 POWDER, FOR SUSPENSION in 1 CARTON

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 73063-035-04?

    The NDC Packaged Code 73063-035-04 is assigned to a package of 7 powder, for suspension in 1 carton of Relyvrio, a human prescription drug labeled by Amylyx Pharmaceuticals Inc. The product's dosage form is powder, for suspension and is administered via oral form.This product is billed for "EA" each discreet unit and contains an estimated amount of 7 billable units per package.

    Is NDC 73063-035 included in the NDC Directory?

    Yes, Relyvrio with product code 73063-035 is active and included in the NDC Directory. The product was first marketed by Amylyx Pharmaceuticals Inc on September 29, 2022 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 73063-035-04?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 7.

    What is the 11-digit format for NDC 73063-035-04?

    The 11-digit format is 73063003504. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-273063-035-045-4-273063-0035-04